Next |
home / stock / syrs / syrs message board
Subject | By | Source | When |
---|---|---|---|
$SYRS got some short data | INFINITI | investorshub | 05/01/2023 9:56:01 PM |
$SYRS where is the squeeze? | trustbutverifyit | investorshub | 04/29/2023 9:14:08 AM |
Price trading | crudeoil24 | investorshub | 04/27/2023 10:02:17 PM |
best news of the day | crudeoil24 | investorshub | 04/24/2023 8:26:18 AM |
Price now last up | XenaLives | investorshub | 04/23/2023 7:20:43 AM |
$SYRS bears are running | crudeoil24 | investorshub | 04/20/2023 3:26:16 AM |
we got news | crudeoil24 | investorshub | 04/19/2023 9:53:44 AM |
$SYRS great article | ClayTrader | investorshub | 04/19/2023 1:04:21 AM |
$SYRS good read | INFINITI | investorshub | 04/18/2023 6:39:17 PM |
$SYRS The now last trade up | XenaLives | investorshub | 04/16/2023 12:28:12 AM |
$SYRS Price now up | Greenspam3 | investorshub | 04/14/2023 6:31:58 PM |
bears and bulls | XenaLives | investorshub | 04/13/2023 5:58:37 PM |
$SYRS: Stock moves quickly on low volume. Large | Mr. Money$ | investorshub | 04/10/2023 1:52:31 PM |
$SYRS: Does anyone have any information on Syros | Mr. Money$ | investorshub | 04/10/2023 1:50:53 PM |
$SYRS Price gaining up | PennyPusher786 | investorshub | 04/09/2023 10:57:34 AM |
$SYRS Price gaining last up | INFINITI | investorshub | 04/08/2023 9:10:10 PM |
$SYRS MomentumIts gaining up | hedge_fun | investorshub | 04/07/2023 5:43:05 AM |
$SYRS The trading | PennyPusher786 | investorshub | 04/06/2023 7:19:47 PM |
$SYRS Price gaining up | knrorrel | investorshub | 04/06/2023 11:45:08 AM |
and the shorts continue | hedge_fun | investorshub | 04/04/2023 3:09:27 AM |
News, Short Squeeze, Breakout and More Instantly...
Syros Pharmaceuticals Inc. Company Name:
SYRS Stock Symbol:
NASDAQ Market:
2024-05-17 13:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
– Passed Interim Futility Analysis of the Primary Endpoint in Phase 3 SELECT-MDS-1 Trial of Tamibarotene; Pivotal CR Data Expected by Mid-4Q 2024; Company to Host HR-MDS-focused Webcast Event with Medical Experts on June 25, 2024 – – Received FDA Fast Track Designatio...